微生物来源的免疫抑制剂国内外生产研发状况与市场分析.pdfVIP

Chinese Journal ofN ew Drugs 2011, 20( 2) # # , (中国药科大学生命科学与技术学院, 南京 210009) [] 如今器官移植已经成为现代医学治疗的重 手段之 一, 但是移植产生的排斥反应给患者的治 疗带来了极大的风险免疫抑制剂的使用有效地抑制了这种危险, 并提高了器官移植的成功率其中, 微生 物产生的免疫抑制剂占据了绝大部分市场份额另外, 随着生物技术的不断应用, 微生物来源的免疫抑制剂 新品种的不断涌现给进行器官移植的患者带来了福音本文分析了该类免疫抑制剂的国内外生产状况研 发进展及市场信息, 以期为相关企业制定营销战略决策起导向作用 [] 微生物; 免疫抑制剂; 国内外; 生产情况; 研发进展; 市场分析 [] R97915 [] A [] 1003- 3734(2011) - 02- 0129- 08 Abroad and hom e production situations, RD progress andm arket analysis of imm unosuppressive agents from m icroorganism s GU Jue-fen, WANGW ei ( Institute of Lfi e Science and Technology, China P harmaceu tical University, Nanj ing 210009, China) [Abstract] Currently organ transplantation has been applied as one of the mi portantmeansofmedical trea-t ment, but allograft rejection hasbrought great risk to patients1 The use of mi munosuppressive agents has restrained the danger and increased the success rate of organ transplantation1 Among these agents, the mi munosuppressive a- gents from m icroorganism shadm ade up an absolute share in the market1 In addition, w ith the continuous applica- tion of biotechnology, the introductions of new products had brought good news to patientsw ith organ transplanta- tion1 The production situation, RD progress andmarket information of mi munosuppressive agentswere analyzed in detail1W e expect to provide references for the relevant enterprises and government departments to formulate bus-i ness strategies1 [K ey words] m icroorganism; mi munosuppressive agents; abroad and home; production situation; RD progress; m arket analysis , 20 70, , 2008 6, , 2008,